Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/childneurology

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Child Neurology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gieselmann, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gieselmann, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Metachromatic Leukodystrophy: Recent Research Developments

Volkmar Gieselmann

Institute of Physiological Chemistry, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany, gieselmann{at}institut.physiochem.uni-bonn.de

Metachromatic leukodystrophy is a lysosomal storage disorder caused by the deficiency of arylsulfatase A, causing the storage of the sphingolipid sulfatide. The disease is characterized by a progressive demyelination, which results in severe, finally lethal, neurologic symptoms. Genetically, the disease is heterogeneous, most mutant alleles are private, and only three have a frequency worth mentioning. An arylsulfatase A—deficient knockout mouse displays some of the disease features seen in patients but does not show the widespread demyelination characteristic of the disease. Nevertheless, this animal model was used to investigate the therapeutic potential of bone marrow stem cell—based gene therapy. Although treated animals show considerable arylsulfatase A activity in many tissues, including the brain, the effect on sulfatide storage was disappointing. Only in the kidney and liver of animals with very high enzyme levels was lipid storage positively affected. In particular, no effect was seen in the brain. These results suggest that bone marrow stem cell—based gene therapy could be of limited value in the treatment of this disease. The pathogenesis of the disease is poorly understood. It is not yet known how sulfatide storage negatively affects the metabolism of the oligodendrocyte. The amount and distribution of various proteins in the myelin of arylsulfatase A—deficient mice were investigated. It was shown that the myelin protein, myelin and lymphocyte protein (MAL), is reduced in deficient animals and that the myelin protein proteolipid displays an altered distribution within the myelin membranes. Possibly, these alterations contribute to the development of demyelination in this disease. (J Child Neurol 2003;18:591—594).

Journal of Child Neurology, Vol. 18, No. 9, 591-594 (2003)
DOI: 10.1177/08830738030180090301


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. B. White, M. I. Givogri, A. Lopez-Rosas, H. Cao, R. van Breemen, G. Thinakaran, and E. R. Bongarzone
Psychosine Accumulates in Membrane Microdomains in the Brain of Krabbe Patients, Disrupting the Raft Architecture
J. Neurosci., May 13, 2009; 29(19): 6068 - 6077.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Anupriwan, M. Schenk, K. Kongmanas, R. Vanichviriyakit, D. Costa Santos, A. Yaghoubian, F. Liu, A. Wu, T. Berger, K. F. Faull, et al.
Presence of Arylsulfatase A and Sulfogalactosylglycerolipid in Mouse Ovaries: Localization to the Corpus Luteum
Endocrinology, August 1, 2008; 149(8): 3942 - 3951.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Ramakrishnan, K. K. Hedayati, R. Lullmann-Rauch, C. Wessig, S. N. Fewou, H. Maier, H.-H. Goebel, V. Gieselmann, and M. Eckhardt
Increasing Sulfatide Synthesis in Myelin-Forming Cells of Arylsulfatase A-Deficient Mice Causes Demyelination and Neurological Symptoms Reminiscent of Human Metachromatic Leukodystrophy
J. Neurosci., August 29, 2007; 27(35): 9482 - 9490.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. I. Givogri, F. Galbiati, S. Fasano, S. Amadio, L. Perani, D. Superchi, P. Morana, U. Del Carro, S. Marchesini, R. Brambilla, et al.
Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy.
J. Neurosci., March 22, 2006; 26(12): 3109 - 3119.
[Abstract] [Full Text] [PDF]